Lymph node architecture preceding and following 6 months of potent antiviral therapy: Follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient

AIDS

Volumn 13, Issue 16, 1999, Pages 2219-2229

  Orenstein, Jan M ^a   Feinberg, Mark ^b   Yoder, Christian ^c   Schrager, Lewis ^d   Mican, JoAnn M ^d   Schwartzentruber, Douglas J ^e   Davey Jr , Richard T ^d   Walker, Robert E ^d   Falloon, Judith ^d   Kovacs, Joseph A ^f   Miller, Kirk D ^f   Fox, Cecil ^c   Metcalf, Julia A ^d   Masur, Henry ^f   Polis, Michael A ^d  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Molecular Histology Laboratory   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

AIDS; Highly active antiretroviral therapy; HIV; Immunohistochemistry; In situ hybridization; Lymph nodes; P24; Transmission electron microscopy

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GAG PROTEIN; HISTONE H3; INDINAVIR; KI 67 ANTIGEN; LAMIVUDINE; MESSENGER RNA; NEVIRAPINE; VIRUS PROTEIN; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENCY; FEMALE; FOLLOW UP; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTE COUNT; LYMPH FOLLICLE; LYMPH NODE; LYMPH NODE HYPERPLASIA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA;

EID: 0032737237     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199911120-00004     Document Type: Article

References (31)

1. 1. Tenner-Racz K, Stellbrink HJ, Van Lunzen J, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998, 187:949-959.
2. 2. Ruiz L, Van Lunzen J, Arno A, et al. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. AIDS 1999, 13:F1-F8.
3. 3. Zhang Z-Q, Schuler T, Cavert W, et al. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci USA 1999, 96:5169-5172.
4. 4. Lafeuillade A, Poggi C, Tamalet C, Profizi N. Human immunod-eficiency virus type 1 dynamics in different lymphoid tissue compartments, J Infect Dis 1997, 176:804-806.
5. 5. Harris M, Patenaude P, Cooperberg P, et al., and the INCAS Study Croup. Correlation of virus load in plasma and lymph node tissue in human immunodeficiency virus infection. J Infect Dis 1997, 176:1388-1392.
6. 6. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
7. 7. Notermans DW, Jurriaans S, de Wolf F, et al. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. AIDS 1998, 12:167-173.
8. 8. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-358.
9. 9. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-362.
10. 10. Feinberg MB. Changing the natural history of HIV disease. lancet 1996, 348:239-246.
11. 11. Fauci AS. Immunopathogenesis of HIV infection. J Acquired Immun Defic Syndr 1993, 6:655-662.
12. 12. Graziosi C, Soudeyns H, Rizzardi GP, Bart P-A, Chapuis A, Pantaleo C. Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses 1998, 14:S135-S142.
13. 13. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861.
14. 14. Wahl SM, Orenstein JM. Immune stimulation and HIV-1 viral replication. J Leukoc Biol 1997, 62:67-71.
15. 15. Wahl SM, Orenstein JM, Smith PD. Macrophage functions in HIV-1 infection. In: Immunology of HIV infection. Gupta S (editor). New York: Plenum Press; 1996. pp. 303-336.
16. 16. Chou MY. A rapid method to determine proliferation patterns of normal and malignant tissues by H3 histone mRNA in situ hybridization. Am J Pathol 1990, 136:729-733.
17. 17. Fox CH, Cottler-Fox M. In situ hybridization for detection of HIV RNA in cells and tissues. In: Current protocols in immunology. Coligan J, Kruisbeek A, Margulies D, Shevach E, Strober W (editors). New York: Wiley; 1993.
18. 18. Foudraine NA, Hovenkamp E, Notermans DW, et al. Immunopathology as a result of highly active anteretroviral therapy in HIV-1 infected patients. AIDS 1999, 13:177-184.
19. 19. Arno A, Ruiz L, Juan M, et al. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years. AIDS 1998, 12:697-704.
20. 20. Li TS, Tubiana R, Katlama C, Calvez V, Mohand HA, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease, Lancet 1998, 351:1682-1686.
21. 21. Orenstein JM, Wahl SM. The multinucleated origin of the HIV-expressing multinucleated giant cells in hyperplastic tonsils and adenoids. J Ultrastruct Pathol 1999, 23:79-91.
22. 22. Lafeuillade A, Chollet L, Hittinger G, Profizi N, Costes O, Poggi C. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of < 200 copies/ml. J Infect Dis 1998, 177:235-238.
23. 23. Dianzani F, Antonelli G, Riva E, Uccini S, Visco G. Plasma HIV viremia and viral load in lymph nodes. Nat Med 1996, 2:832-833.
24. 24. Montaner JSG, Hogg R, Raboud J, Harrigan R, O'Shaughnessy M. Antiretroviral treatment in 1998. Lancet 1998, 352:1919-1922.
25. 25. Gunthard HF, Wong JK, Ignacio CC, Guatelli JC, Riggs NL, Havlir DV, Richman DD. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol 1998, 72:2422-2428.
26. 26. Wong JK, Gunthard HF, Havlir DV, et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 1997, 94:12574-12579.
27. 27. Jubault V, Burgard M, Le Corfec E, Costagliola D, Rouzioux C, Viard JP. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. AIDS 1998, 12:2358-2359.
28. 28. Staszewski S, Miller V, Sabin C, Berger A, Hill AM, Phillips AN. Rebound of HIV-1 viral load after suppression to very low levels. AIDS 1998, 12:2360.
29. 29. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
30. 30. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
31. 31. Furtado MR, Callaway DS, Phair JP, et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 1999, 340:1614-1622.